3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Conditions
Vomiting
1
Neoplasms
1
Nausea
1
Interventions
Dexamethasone
17
Palonosetron
13
Aprepitant
13
Ondansetron
12
Calcium Dobesilate
12
Granisetron
7
dexamethasone acetate
5
Doxorubicin
5
Cyclophosphamide
4
fosaprepitant
3
dexamethasone 21-phosphate
3
Vincristine
3
Olanzapine
3
Cisplatin
3
Therapeutics
2
Sugars
2
Radiotherapy
2
Mesna
2
Lorazepam
2
Ifosfamide
2
Fluorouracil
2
Dronabinol
2
Diphenhydramine
2
rolapitant
1
netupitant
1
isatuximab
1
ginger extract
1
dolasetron
1
casopitant
1
auricularum
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Nausea
×
dolasetron
×
Clear all
NCT01636947
2018-09-25
KMEC
Merck Sharp & Dohme LLC
Phase 4
Completed
494 enrolled
14 charts